Lonza Deal History & Licensing Activity
Lonza is a life sciences. Over the past three years, Lonza has been involved in 2 licensing and acquisition transactions, with a primary focus on ADC (4 deals).
Deals (12mo)
2
Active Trials
0
Top Modality
ADC
Focus Area
Oncology
Lonza Recent Deal Activity
Licensing, acquisition, and partnership transactions involving Lonza in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| STP-100 | Stipple Bio | ADC | Preclinical | license | Jun 4, 2026 |
| SYNtecan linker-payload platform | Bristol-Myers Squibb | ADC | Unknown | license | May 7, 2026 |
Lonza Pipeline Focus
Therapeutic areas and modalities where Lonza is most active based on deal history and clinical trial data.
See How Your Asset Matches Lonza's Portfolio
Use Solidus to benchmark upfront payments, milestones, and royalties for Oncology assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Oncology Deal Benchmarks
Market sizing, deal terms, and competitive landscape for oncology
ADC Benchmarks
Upfront, milestone, and royalty benchmarks for adc deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 700+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
Industry-wide analysis of deal terms, trends, and market dynamics
About Lonza Licensing & Deal Activity
Lonza is a life sciences company that has been actively engaged in licensing transactions across the biopharma landscape. With 2 deals over the past three years, Lonza ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for Lonza include Oncology (4 deals and trials). In terms of modality, Lonza has shown particular interest in adc.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Lonza and 700+ other biopharma companies. Use our Solidus to benchmark your asset against Lonza's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.